Young Investigator Award

 

The Young Investigator Award in Cognitive Neuroscience recognizes outstanding contributions by scientists early in their careers. Award recipients have been working in the area of cognitive neuroscience for no more than 10 years involved in active independent research.

The FLUX Society is pleased to announce the call for nominations for the Young Investigator Award in Cognitive Neuroscience for the 2018 year.

Eligibility

For the 2018 awards, the nominee MUST be:

  1. Working in any area of cognitive neuroscience
  2. No more than 10 years involved in active independent research as of April 1, 2018
  3. Residency, clinical internship and interruption for childbearing will not be counted against the 10-year limit
  4. Nominated by a Flux member (no self-nominations will be accepted)
  5. In attendance at the 2018 meeting to accept the award in person and agree to give a special plenary lecture

Submitting a Nomination

Before submitting a nomination, collect the required materials:

  • Contact information for the nominee
  • A PDF or Word Document of the nominee’s CV
  • A short (max 600) word statement of the nominee’s research program
  • A PDF or Word Document of a nomination statement from the primary referee
  • Contact information for a second referee

When submitting your nomination, please send all documentation in a PDF or Word document and NOT in the body of the email. For questions please contact us.

Click here to email us your nomination with supporting documentation.

Submission Deadline: May 15, 2018, 23:59 Central Time

Flux 2018 Young Investigator Award Winner

Leah Somerville is an Associate Professor of Psychology and faculty member of the Center for Brain Science at Harvard University. Since joining the faculty at Harvard in 2012, she has been the director of the Affective Neuroscience and Development Laboratory. The lab’s research integrates psychological and neuroscientific approaches to inform how the way in which the brain develops through adolescence shapes psychological changes in cognitive, motivational, social, and emotional behavior. Leah’s lab has become engaged in conducting the Human Connectome Project in Development, which is a large, NIH-funded study on multimodal brain connectivity across development from middle childhood to early adulthood. More broadly, this work is aimed at revealing the mechanisms underlying unique features of adolescent emotions, decision-making, and risk for mental illness.

Leah completed her bachelors degree at the University of Wisconsin, her PhD at Dartmouth College, and postdoctoral training at Weill Cornell Medical College. Her work is funded by the National Science Foundation, Brain and Behavior Research Foundation, American Psychological Association, and National Institutes of Health.

Leah will be presenting her Young Investigator Award talk at the Flux Congress on Friday, August 31.

Flux 2017 Young Investigator Award Winner

Dr. Damien Fair obtained his BA degree in 1998 from Augustana College, S.D. In 2001, he graduated with a master of medical science degree from the physician associate program at the Yale University School of Medicine, and practiced until 2003 at Yale-New Haven Hospital. He entered the neuroscience graduate program at the Washington University in St. Louis under the guidance of Bradley Schlaggar, M.D., Ph.D. and Steven Petersen, Ph.D. His postdoctoral fellowship was at Oregon Health & Science University under the direction of Joel Nigg Ph.D. He’s now an Associate Professor in the Behavioral Neuroscience Department at OHSU.

Dr. Fair’s laboratory focuses on mechanisms and principles that underlie the developing brain. The majority of this work uses functional & functional connectivity MRI to assess typical and atypical populations. A second focus of his lab involves testing the feasibility of using various functional and structural MRI techniques in translational studies of developmental neuropsyciatric disorders. He is exploring ways to better characterize individual patients with these psychopathologies to help guide future diagnostic, therapeutic and genetic studies.